基本信息
浏览量:53
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Battistini is a director and test facility management at the nonclinical CRO - Charles River Laboratories in Sherbrooke, and a senior consultant to many research projects for academic institutions and private sector enterprise. Before becoming New Brunswick's President, CEO and Scientific Director of the Provincial Health Research Foundation (NBHRF; 2012-2018), Bruno Battistini occupied senior positions in the private sector (CSO, VP, Senior Director), was a Health Research Scholar (FRQS) and Assistant-Professor (Medicine) at the Université Laval (1997-2006), and Scientist at the Hôpital Laval - Quebec Heart & Lung Institute (1997-2006), and still lectures at the Université de Sherbrooke and is an Adjunct-Professor at the University of Ottawa (2020-__). Dr. Battistini continues to serves on several provincial (as Chair of the CQDM-FACS-Research Oversight Committee, a program from MEI-gouv.qc of $100M over 4 years) and national advisory committees, peer-review committees, and boards.
Dr. Battistini holds a B.Sc. (Cell Physiology), M.Sc. and PhD (Pharmacology; 1992) from the Université de Sherbrooke, QC. As a Fellow, he conducted three post-doctoral trainings (1992-1997) at the William Harvey Research Institute - St. Bartholomew’s Hospital Medical College - U of London - under Sir John R. Vane, Nobel Laureate, UK, then UBC-Vancouver and U de Sherbrooke. He has been awarded back in the days with many health research Studentships, Fellowships and Scholarships and was in receipt of several operating grants and venture capitals funds. He was the national Co-Chair of www.NAPHRO.ca and the Forum of Health Research (Canadian) Funders (2015-2017), and is the recipient of many national awards and honours.
His research focused in the cardiovascular, pulmonary and "diabesity" fields, with 128 co-authored cited publications (128 research works with 3109 citations and 1670 reads), a couple of patents, and over 350 various posters, oral, keynote presentations, particularly on the mechanisms of endothelins and other vasoactive mediators in hypertension, sepsis, asthma, alveolitis, diabetes, and more recently in managing major scientific and social health endeavours. When a Faculty, he has trained over 20 students. Over the past two years, he co-founded www.pulmonem.ca which is the private sector company engaged in the clinical trial of a treatment, not a vaccine, against COVID (www.dapcorona.com).
He continues (>2018) to actively participate or Lead oversight, evaluation and surveillance committees, as a consultant to foster the development of major proposals, new initiatives, strategic alliance, business development, & licensing agreements.
Visit:
https://www.researchgate.net/scientific-contributions/Bruno-Battistini-53723978
https://scholar.google.ca/citations?user=xpSB_NAAAAAJ&hl=en
https://www.semanticscholar.org/author/B.-Battistini/5931065
https://ca.linkedin.com/in/bruno-j-battistini-63514a7
研究兴趣
论文共 156 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Health research policy and systemsno. 1 (2023): 52-13
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn